OR WAIT null SECS
October 06, 2017
Under an agreement, ProBioGen will develop a stable cell-line for and manufacture an anti-cancer antibody for Chiome using its proprietary cancer cell-killing technology.
October 04, 2017
Under Project BioShield, the agency could provide more than $170 million in funding to purchase and support late-stage development of Ebola vaccines and therapeutic drugs.
October 03, 2017
GE Healthcare opened a 3D printing lab in Sweden that will speed the launch of products for bio/pharma manufacturing, such as a custom chromatography column.
October 02, 2017
Tools aid scale-up and comparison of single-use and stainless-steel bioreactors.
September 14, 2017
Shingrix represents a new, possibly better alternative to existing treatments.
August 30, 2017
FDA approves Novartis’ CAR-T therapy, marking the first time a cell therapy based on gene transfer has been approved in the United States for any indication.
July 24, 2017
Industry collaboration group releases technology roadmap to address pressure on biopharmaceutical manufacturers to innovate biomanufacturing processes.
June 27, 2017
Drug sales forecasts fall for first time in 10 years, thanks to pressures to reduce drug prices and the advent of biosimilars.
June 22, 2017
A loan from the European Investment Bank will give BiondVax resources for Phase III trials and a manufacturing facility for its universal flu vaccine.
June 12, 2017
The landmark decision determined that biosimilar makers can notify manufacturers before receiving FDA approval.